Murphy, L O <br/><br/>
Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions.  [electronic resource] 

 -  British journal of cancer  Apr 2001 
 - 926-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1054/bjoc.2001.1698  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Division--physiology<br/>Culture Media, Serum-Free<br/>Enzyme Activation<br/>Enzyme Inhibitors--pharmacology<br/>Epidermal Growth Factor--metabolism<br/>ErbB Receptors--metabolism<br/>Flavonoids--pharmacology<br/>Gastrin-Releasing Peptide--metabolism<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>MAP Kinase Signaling System--physiology<br/>Mitogen-Activated Protein Kinase 1--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 3<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Pancreatic Neoplasms--metabolism<br/>Quinazolines<br/>Substrate Specificity<br/>Transcription Factor AP-1--biosynthesis<br/>Tumor Cells, Cultured<br/>Tyrphostins--pharmacology